← FDA Drug Approvals (Drugs@FDA)
NYSTATIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: STERANCO HLTHCARE · Approved 2026-02-05
Drug application
- FDA Application #
ANDA220367- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NYSTATIN
- Generic name
- Nystatin
- Active ingredients
- NYSTATIN
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- STERANCO HLTHCARE
- First approval
- 2026-02-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown